N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2007

Study Completion Date

February 29, 2008

Conditions
Heart Failure, CongestiveKidney Failure, Chronic
Interventions
DRUG

N-acetylcysteine

28 days of oral n-acetylcysteine (500mg bd)(in addition to standard therapy) and then repeat serum creatinine and vascular study then crossover to placebo for 28 days after one week washout period with tests repeated again at 4 weeks and 9 weeks.

Trial Locations (1)

3004

RECRUITING

Alfred Hospital, Melbourne

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

The Alfred

OTHER

lead

Bayside Health

OTHER_GOV